Noninvasive diagnosis of renal osteodystrophy (literature review)



Cite item

Full Text

Abstract

This review concerns to “Chronic kidney disease-mineral and bone disorder” (CKD-MBD). This term is used to describe a set of biochemical abnormalities, bone disturbances that may lead to fractures, and extraskeletal calcification in soft tissues and arteries seen in CKD. Renal osteodystrophy (ROD) is a part of the CKD-MBD, the bone biopsy is the gold standard to diagnose it, but it is not clinically practical for studying continuous changes in bone morphology. The recent studies concern to the noninvasive diagnosis of renal osteodystrophy to predict fracture risk and optimize the therapy.

References

  1. WORLD HEALTH ORGANIZATION: Burden of disease project. Available at http://www3.who.int/. Accessed September 2004
  2. KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Kidney International (2009) 76, S3-S8 doi: 10.1038/ki.2009.189.
  3. Кузина Н.Ю., Орлова Г.М. Некоторые эффекты вторичного гиперпаратиреоза у больных с хронической болезнью почек. Нефрология и диализ - 2008 - Т.10, № 2. - с. 140-143.
  4. Ranjani N Moorthi, Sharon M Moe. Recent advances in the noninvasive diagnosis of renal osteodystrophy. Kidney International, 2013.
  5. Koivula MK, Risteli L, Risteli J. Measurement of aminoterminal propeptide of type I procollagen (PINP) in serum. Clin Biochem 2012 45: 920-927.
  6. Milliner D.S., Zinsmeister A.R., Lieberman E., Landing B. Soft tissue calcification in pediatric patients with end-stage renal disease // Kidney Int.-1990-Vol.38, № 5.-P.931-936.
  7. Ganesh SK, Stack AG, Levin NW, et al: Association of elevated serum PO (4), Ca _ PO (4) product and parathyroid hormone with mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 12:2113, 2001.
  8. Yenchek RH, Ix JH, Shlipak MG et al. Bone mineral density and fracture risk in older individuals with CKD. Clin J Am Soc Nephrol 2012 7: 1130-1136.
  9. Jamal SA, Hayden JA, Beyene J. Low bone mineral density and fractures in long-term hemodialysis patients: a meta-analysis. Am J Kidney Dis 2007 49: 674-681.
  10. Ambrus C, Almasi C, Berta K et al. Vitamin D insufficiency and bone fractures in patients on maintenance hemodialysis. Int Urol Nephrol 2011 43: 475-482.
  11. Ranjani N Moorthi, Sharon M Moe. Recent advances in the noninvasive diagnosis of renal osteodystrophy. Kidney International, 2013.
  12. Tilman B Drüeke and Ziad A Massy. Circulating Klotho levels: clinical relevance and relationship with tissue Klotho expression. Kidney International (2013) 83, 13-15.
  13. Bhattacharyya N, Chong WH, Gafni RI, Collins MT. Fibroblast growth factor 23: state of the field and future directions. Trends Endocrinol Metab. 2012 Dec;23(12):610-8.
  14. Institute of Medicine. Dietary References Intakes: Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. National Academy Press 1997.
  15. Wesseling-Perry K, Pereira RC, Wang H et al. Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis. J Clin Endocrinol Metab 2009 94: 511-517.
  16. Razzaque MS. Does FGF23 toxicity influence the outcome of chronic kidney disease? Nephrol Dial Transplant. 2009 Jan;24(1):4-7.
  17. Jean G, Bresson E, Terrat JC et al. Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences.Nephrol Dial Transplant 2009 24: 948-955.
  18. Middleton R.J., Parfrey P.S., Foley R.N. Left ventricular hypertrophy in the renal patient. Am. J. Soc. Nephrol. 2001 12:1079-84.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2013 Upolovnikova V.S., Romasheva E.P., Rubanenko O.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies